Skip to Main Content

Advertisement

Skip Nav Destination

Abstract LB-195: Anti-CD40 and CpG-ODN enhance the antimelanoma response of hu14.18K322A in vivo.

Cancer Res (2010) 70 (8_Supplement): LB-195.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal